Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300042 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Lilian Hor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, School of Agriculture, Biomedicine and Environment, La Trobe Univ…. Hauptthemen laut MEDLINE: Complement Activation, Mannose-Binding Lectin, Mannose-Binding Protein-Associated Serine Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
The activation of the CP/LP C3 proconvertase complex is a key event in complement activation and involves cleavage of C4 and C2 by the C1s protease (classical pathway) or the mannose-binding lectin–associated serine protease (MASP)-2 (lectin pathway). Efficient cleavage of C4 by C1s and MASP-2 involves exosites on the complement control protein and serine protease (SP) domains of the proteases. The complement control protein domain exosite is not involved in cleavage of C2 by the proteases, but the role of an anion-binding exosite (ABE) on the SP domains of the proteases has (to our knowledge) never been investigated. In this study, we have shown that the ABE on the SP of both C1s and MASP-2 is crucial for efficient cleavage of C2, with mutant forms of the proteases greatly impaired in their rate of cleavage of C2. We have additionally shown that the site of binding for the ABE of the proteases is very likely to be located on the von Willebrand factor domain of C2, with the precise area differing between the enzymes: whereas C1s requires two anionic clusters on the von Willebrand factor domain to enact efficient cleavage of C2, MASP-2 apparently only requires one. These data provide (to our knowledge) new information about the molecular determinants for efficient activation of C2 by C1s and MASP-2. The enhanced view of the molecular events underlying the early stages of complement activation provides further possible intervention points for control of this activation that is involved in a number of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Victoria, Australia.
- Australian Research Council Centre of Excellence in Advanced Molecular Imaging, La Trobe University, Melbourne, Victoria, Australia.
ORCID-Profile: Lilian Hor, Jing Pan, Robert N Pike, Lakshmi C Wijeyewickrema
Förderung
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Hor, L., Pan, J., Pike, R. N., & Wijeyewickrema, L. C. (2024). Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300042
Vancouver
Hor L, Pan J, Pike RN, Wijeyewickrema LC. Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300042
BibTeX
@article{Hor2024,
author = {Hor, Lilian and Pan, Jing and Pike, Robert N and Wijeyewickrema, Lakshmi C},
title = {Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300042}
}
EUVIMED